FAAH Inhibitor Trial for Adults With Tourette Syndrome

Trial Profile

FAAH Inhibitor Trial for Adults With Tourette Syndrome

Phase of Trial: Phase II

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs PF 4457845 (Primary)
  • Indications Gilles de la Tourette's syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Mar 2016 Status changed from recruiting to suspended due to the clinical hold placed on the study pending results from another study, according to ClinicalTrials.gov record.
    • 24 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top